Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05384015
Title Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer (PEERS)
Acronym PEERS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion GECP
Age Groups: adult | senior
Covered Countries ESP

No variant requirements are available.